Barbara Klencke
CIK 1647647 · Chief Medical Officer · last filed 2026-05-22
Barbara Klencke is a Chief Medical Officer who has filed 34 SEC Form 4 insider transactions across 6 companies since 2016. The most recent filing, for TCRX, was dated May 22, 2026. Across all open-market trades the lifetime net is +$322.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $306.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$306.4K
6
34
$322.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCRX | Director | 70,000 | $0.91 | $63.8K | $108.0K | 8 | 2026-05-22 |
| ALXO | Chief Medical Officer | — | $1.58 | — | $0 | 4 | 2026-04-17 |
| XNCR | Director | 19,672 | $12.33 | $242.6K | $0 | 3 | 2025-06-16 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Director | — | $0.00 | — | $0 | 6 | 2024-06-13 |
| Sierra Oncology, Inc. (SRRA) Delisted | Chief Medical Officer | 0 | $54.99 | $0 | $214.1K | 11 | 2022-07-01 |
| Sierra Oncology, Inc. (DNAI) Delisted | Chief Development Officer | — | — | — | $0 | 2 | 2016-10-04 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2026-04-17 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2026-03-05 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2025-09-19 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | XNCR | Grant (A) | +13,686 | $0 | EDGAR |
| 2025-01-23 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-09-24 | TCRX | Buy (P) | +5,000 | $26.4K | EDGAR |
| 2024-08-27 | TCRX | Buy (P) | +10,000 | $56.1K | EDGAR |
| 2024-06-17 | XNCR | Grant (A) | +5,986 | $0 | EDGAR |